NEW YORK (GenomeWeb) – The GenomeWeb Index rose 2 percent in June, outperforming the Dow Jones Industrial Average and the Nasdaq — which gained less than 2 percent and lost 1 percent, respectively — but vastly underperforming the Nasdaq Biotechnology Index, which gained nearly 9 percent.

Stock performance in the June GenomeWeb Index was mostly positive with 19 of the 26 stocks seeing gains and only seven seeing losses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.